Evidence map›Paper›PMID 36026521›Full record

Observational studyEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology2022

Novel cryoballoon ablation system for pulmonary vein isolation: multicenter assessment of efficacy and safety-ANTARCTICA study.

Christian-H Heeger, Alexander Pott, Christian Sohns, Lisa Riesinger, Philipp Sommer, Alessio Gasperetti, Claudio Tondo, Gaetano Fassini, Fabian Moser, Philipp Lucas and 8 more

Registry-linked trialOpen access · bronzeAbstract readObservational StudyMulticenter Study
In one paragraph

Observational study in Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05603091 (Pressure Wave Guided Atrial Fibrillation Cryoablation), which is not on this map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05603091 unknown statusnot on this map

Pressure Wave Guided Atrial Fibrillation Cryoablation: POLAR-WAVE Registry

Typeobservational_patient_registrySponsorHospital Universitario 12 de OctubreRan2022 to 2024Enrolled100ConditionsAtrial FibrillationArmscryoablation of pulmonary veins
3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Impact of cryoballoon size adjustability on procedural and clinical outcomes.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. In vivo safety and pulmonary vein isolation performance of a new cryoballoon for the treatment of atrial fibrillation.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2024
    Article
  8. Pressure waveform analysis for occlusion assessment significantly reduces contrast medium use in cryoballoon pulmonary vein isolation.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2024
    Article
  9. Article
  10. Article
  11. Incidence of phrenic nerve injury during pulmonary vein isolation using different cryoballoons: data from a large prospective ablation registry.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Observational
  12. Feasibility and efficacy of a novel size adjustable cryoballoon for ablation of atrial fibrillation.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2024
    Article
  13. Article
  14. Article
  15. Acute and long-term results with the 3Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2024
    Article
  16. Article
  17. Article
  18. Efficacy and safety of pulmonary vein isolation with pulsed field ablation vs. novel cryoballoon ablation system for atrial fibrillation.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Article
  19. Atrial fibrillation cryoablation is an effective day case treatment: the UK PolarX vs. Arctic Front Advance experience.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Article
  20. Novel or established cryoballoon ablation system for pulmonary vein isolation: the prospective ICE-AGE-1 study.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 2 countries.

Christian-H HeegerUniversity Heart Center Lübeck, Department of Rhythmology, University Hospital Schleswig-Holstein (UKSH), Ratzeburger Allee 160, D-23538 Lübeck, Germany.ORCID 0000-0002-9014-8097
Alexander PottInternal Medicine II, Department of Cardiology, Ulm, Germany.ORCID 0000-0002-5824-8098
Christian SohnsHerz und Diabeteszentrum, Klinik für Rhythmologie, Herz- und Diabeteszentrum NRW, Bad Oeynhausen, Germany.ORCID 0000-0003-0490-5862
Lisa RiesingerUniversitätsklinikum Essen, Westdeutsches Herz- und Gefäßzentrum Essen, Germany.
Philipp SommerHerz und Diabeteszentrum, Klinik für Rhythmologie, Herz- und Diabeteszentrum NRW, Bad Oeynhausen, Germany.ORCID 0000-0002-3037-8704
Alessio GasperettiCentro Cardiologico Monzino, Heart Rhythm Center at IRCCS Centro Cardiologico Monzino, Milan, Italy.ORCID 0000-0003-3432-070X
Claudio TondoCentro Cardiologico Monzino, Heart Rhythm Center at IRCCS Centro Cardiologico Monzino, Milan, Italy.ORCID 0000-0002-8500-8313
Gaetano FassiniCentro Cardiologico Monzino, Heart Rhythm Center at IRCCS Centro Cardiologico Monzino, Milan, Italy.
Fabian MoserUniversity heart center of Hamburg Eppendorf, Germany.ORCID 0000-0001-7310-6111
Philipp LucasHerz und Diabeteszentrum, Klinik für Rhythmologie, Herz- und Diabeteszentrum NRW, Bad Oeynhausen, Germany.
Karolina WeinmannInternal Medicine II, Department of Cardiology, Ulm, Germany.
Jan-Eric BohnenUniversitätsklinikum Essen, Westdeutsches Herz- und Gefäßzentrum Essen, Germany.
Tillman DahmeInternal Medicine II, Department of Cardiology, Ulm, Germany.
Andreas RilligUniversity heart center of Hamburg Eppendorf, Germany.ORCID 0000-0003-3457-0936
Karl-Heinz KuckUniversity Heart Center Lübeck, Department of Rhythmology, University Hospital Schleswig-Holstein (UKSH), Ratzeburger Allee 160, D-23538 Lübeck, Germany.
Reza WakiliUniversitätsklinikum Essen, Westdeutsches Herz- und Gefäßzentrum Essen, Germany.
Andreas MetznerUniversity heart center of Hamburg Eppendorf, Germany.ORCID 0000-0002-6818-6396
Roland R TilzUniversity Heart Center Lübeck, Department of Rhythmology, University Hospital Schleswig-Holstein (UKSH), Ratzeburger Allee 160, D-23538 Lübeck, Germany.ORCID 0000-0002-0122-7130
Centro Cardiologico Monzino · ITEssen University Hospital · DEHeart and Diabetes Center North Rhine-Westphalia · DEUniversity Hospital Schleswig-Holstein · DEUniversity Medical Center Hamburg-Eppendorf · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsPulmonary vein isolation (PVI) either by balloon devices or radiofrequency forms the cornerstone of invasive atrial fibrillation (AF) treatment. Although equally effective cryoballoon (CB)-based PVI offers shorter procedure duration and a better safety profile. Beside the worldwide established Arctic Front Advance system, a novel CB device, POLARx, was recently introduced. This CB incorporates unique features, which may translate into improved efficacy and safety. However, multicentre assessment of periprocedural efficacy and safety is lacking up to date. METHODS AND

resultsA total of 317 patients with paroxysmal or persistent AF were included and underwent POLARx CB-based PVI in 6 centres from Germany and Italy. Acute efficacy and safety were assessed in this prospective multicenter observational study. In 317 patients [mean age: 64 ± 12 years, 209 of 317 (66%) paroxysmal AF], a total of 1256 pulmonary veins (PVs) were identified and 1252 (99,7%) PVs were successfully isolated utilizing mainly the short tip POLARx CB (82%). The mean minimal CB temperature was -57.9 ± 7°C. Real-time PVI was registered in 72% of PVs. The rate of serious adverse events was 6.0% which was significantly reduced after a learning curve of 25 cases (9.3% vs. 3.0%, P = 0.018). The rate of recurrence-free survival after mean follow-up of 226 ± 115 days including a 90-day blanking period was 86.1%.

conclusionIn this large multicentre assessment, the novel POLARx CB shows a promising efficacy and safety profile after a short learning curve.

Indexed as

Atrial FibrillationCatheter AblationCryosurgeryPulmonary VeinsAgedHumansMiddle AgedProspective StudiesTreatment OutcomeAtrial fibrillationCatheter ablationCryoballoonPulmonary vein isolation

Identifiers

PMID36026521
PMCPMC9733956
OpenAlexW4293150571

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.